Nephropathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-04-03
Clinical Trial Update: A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy [Phase 2]
A Phase 2 trial of Mitapivat in participants with sickle cell disease and nephropathy has been withdrawn.